• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 1.30% Nasdaq Up 1.59%

    Mirati Therapeutics, Inc. (MRTX)

    -NasdaqCM
    5.43 Down 0.14(2.59%) 1:18PM EDT - Nasdaq Real Time Price
    Prev Close:5.57
    Open:5.70
    Bid:5.37 x 1000
    Ask:5.40 x 200
    1y Target Est:22.86
    Beta:1.66062
    Earnings Date:Aug 4 - Aug 8 (Est.)
    Day's Range:5.31 - 5.70
    52wk Range:5.31 - 52.00
    Volume:262,779
    Avg Vol (3m):379,992
    Market Cap:108.01M
    P/E (ttm):N/A
    EPS (ttm):-4.17
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for MRTX

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-4.55
    Quarterly EPS Est (Jun-16) :-1.15
    Mean Recommendation*:2.1
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Mirati Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of products targeting oncology. The company’s clinical stage product candidates include MGCD265, a multi-targeted kinase inhibitor that is in Phase 1b ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback